Price target
8.750.000.00%
The 4 analysts offering 1 year price forecasts for 0LC7 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 5 analysts giving stock ratings to 0LC7 in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
0LC7 EPS for the last quarter is −0.16 USD despite the estimation of −0.68 USD. In the next quarter EPS is expected to reach −0.72 USD. Track more of SYROS PHARMACEUTICALS INC COM USD0.001 (POST REV SPLIT) financials and stay on top of what is up with the company.
In the next quarter SYROS PHARMACEUTICALS INC COM USD0.001 (POST REV SPLIT) revenue is expected to reach 360.00 K USD. Check out SYROS PHARMACEUTICALS INC COM USD0.001 (POST REV SPLIT) revenue and earnings and make informed decisions.
According to analysts, 0LC7 price target is 8.75 USD with a max estimate of 20.00 USD and a min estimate of 4.00 USD. Check if this forecast comes true in a year, meanwhile watch SYROS PHARMACEUTICALS INC COM USD0.001 (POST REV SPLIT) stock price chart and keep track of the current situation with 0LC7 news and stock market news.
We've gathered opinions of 5 analysts rating 0LC7 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.